UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Seegene develops 1st molecular diagnostic reagent using AI
Seegene said Wednesday that it has developed the world’s first molecular di...
by Lee Han-soo
|
2018-01-03 12:12
라인
Ministry to invest ₩349 billion in biotechnology R&D
The Ministry of Science and ICT (MSIT) said Tuesday it would invest 349 bil...
by Lee Han-soo
|
2018-01-03 10:56
라인
Green Cross changes its name to GC Pharma
Green Cross said Tuesday it changed the company name to GC Pharma during th...
by Lee Han-soo
|
2018-01-02 16:48
라인
Samsung BioLogics denies accounting fraud allegations
Samsung BioLogics denied continuous allegations of accounting fraud in a st...
by Lee Han-soo
|
2018-01-02 11:52
라인
Korea Biomedical Review’s ‘Top 20’ news
By all accounts, 2017 was an eventful year for Korea’s medical and pharmace...
by Lee Han-soo
|
2017-12-31 10:59
라인
Yonsei Cancer Center updates international guideline
A research team at Yonsei Cancer Center has recently revised the National C...
by Lee Han-soo
|
2017-12-27 17:51
라인
Blue-ribbon panel discusses medical device regulations
The Presidential Committee on the Fourth Industrial Revolution (PCFIR) said...
by Lee Han-soo
|
2017-12-27 12:55
라인
Large companies lack in public health contributions
Large companies in Korea have long been criticized for monopolizing the ind...
by Lee Han-soo
|
2017-12-26 17:29
라인
Seoul St. Mary’s Hospital performs over 7,000 bone marrow transplants
Seoul St. Mary's hospital's bone marrow transplantation (BMT) cente...
by Lee Han-soo
|
2017-12-26 14:28
라인
LG Chem’s diabetes drug Zemiglo sees fast sales growth
LG Chem said Wednesday that accumulated, combined sales of diabetes drug Ze...
by Lee Han-soo
|
2017-12-21 12:35
라인
Huons Global starts local clinical trial for Hutox
Huons Global said Thursday that it has launched phase 3 local clinical tria...
by Lee Han-soo
|
2017-12-21 11:30
라인
Huons, SMB sign license agreement for Zephirus
Huons, a subsidiary of Huons Global, said Wednesday that it has signed a li...
by Lee Han-soo
|
2017-12-20 17:07
라인
FDA to review Samsung Bioepis’ trastuzumab biosimilar
Samsung Bioepis said Tuesday that the U.S. Food and Drug Administration (FD...
by Lee Han-soo
|
2017-12-20 14:37
라인
SK Chemicals starts domestic supply of ‘Skyzoster’
SK Chemicals said Tuesday that it has started to supply Skyzoster, the firs...
by Lee Han-soo
|
2017-12-20 14:37
라인
Health ministry to foster healthcare as growth industry
The Ministry of Health and Welfare announced Wednesday its plans to foster ...
by Lee Han-soo
|
2017-12-20 12:45
라인
FDA approves gene therapy for rare form of inherited vision loss
The U.S. Food and Drug Administration Tuesday approved Spark Therapeutic’s ...
by Lee Han-soo
|
2017-12-20 10:36
라인
Nature Cell expects to receive conditional approval for Jointstem
Nature Cell showed confidence in obtaining conditional approval for Jointst...
by Lee Han-soo
|
2017-12-19 18:22
라인
Ferring’s oral colonoscopy preparation solution obtains FDA approval
Pharmbio Korea said Tuesday that Ferring Pharmaceuticals, a multi-national ...
by Lee Han-soo
|
2017-12-19 17:02
라인
GemVax wins patent for personalized-tissue engineered vein technology
GemVax Technology, a subsidiary of GemVax & KAEL, said Monday that it has a...
by Lee Han-soo
|
2017-12-19 16:16
라인
Toshiba Medical introduces new MRI device
Vantage Galan 3T Toshiba Medical said Monday that Hongik Hospital has bec...
by Lee Han-soo
|
2017-12-19 14:55
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top